Mainz Biomed B.V. (MYNZ) Revenue History
Annual and quarterly revenue from 2019 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
MYNZ Revenue Growth
MYNZ Revenue Analysis (2019–2024)
As of May 8, 2026, Mainz Biomed B.V. (MYNZ) generated trailing twelve-month (TTM) revenue of $1.6 million, reflecting explosive growth of +73.8% year-over-year. The most recent quarter (Q4 2024) recorded $373,218 in revenue, down 28.3% sequentially.
Looking at the longer-term picture, MYNZ's 5-year compound annual growth rate (CAGR) stands at +26.0%, indicating outstanding long-term growth trajectory. The company achieved its highest annual revenue of $895,479 in 2023.
When compared to Healthcare sector peers including EXAS (+17.7% YoY), GKOS (+36.3% YoY), and NTRA (+35.9% YoY), MYNZ has outperformed the peer group in terms of revenue growth. Compare MYNZ vs EXAS →
MYNZ Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| MYNZCurrent | $2M | +73.8% | +26.0% | -2091.2% | |
 EXAS | $3.2B | +17.7% | +16.8% | -6.4% | |
 GKOS | $507M | +36.3% | +17.7% | -17.1% | |
 NTRA | $2.3B | +35.9% | +42.6% | -13.4% | |
 SDGR | $256M | +10.6% | +18.8% | -65.2% | |
 GH | $982M | +39.6% | +27.9% | -44.4% |
MYNZ Historical Revenue Data (2019–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $894K | -0.2% | $575K | 64.3% | $-18,695,408 | -2091.2% |
| 2023 | $895K | +69.0% | $510K | 56.9% | $-26,644,682 | -2975.5% |
| 2022 | $530K | -8.2% | $182K | 34.4% | $-26,444,040 | -4990.6% |
| 2021 | $577K | +17.0% | $178K | 30.8% | $-9,724,606 | -1684.4% |
| 2020 | $494K | +75.4% | $123K | 24.9% | $-766,090 | -155.2% |
| 2019 | $281K | - | $-61,271 | -21.8% | $-921,909 | -327.6% |
See MYNZ's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MYNZ Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MYNZ vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonMYNZ — Frequently Asked Questions
Quick answers to the most common questions about buying MYNZ stock.
Is MYNZ's revenue growth accelerating or slowing?
MYNZ revenue is accelerating at +73.8% year-over-year, exceeding the 5-year CAGR of +26.0%. TTM revenue reached $2M. Growth momentum has increased versus prior periods.
What is MYNZ's long-term revenue growth rate?
Mainz Biomed B.V.'s 5-year revenue CAGR of +26.0% reflects the sustained expansion pattern. Current YoY growth of +73.8% is above this long-term average.
How is MYNZ's revenue distributed by segment?
MYNZ reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2019-2024 are available for download. Segment mix reveals concentration and diversification trends.